Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Infection, Reinfection, and Vaccine Effectiveness in Arizona Frontline and Essential Workers: Protocol for a Longitudinal Cohort Study
Karen Lutrick, Katherine Ellingson, Zoe Baccam, et al.
JMIR Research Protocols (2021) Vol. 10, Iss. 6, pp. e28925-e28925
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
Ashley Fowlkes, Manjusha Gaglani, Kimberly Groover, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 34, pp. 1167-1169
Open Access | Times Cited: 285
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
Sarang K Yoon, Kurt T. Hegmann, Matthew S. Thiese, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1855-1857
Open Access | Times Cited: 44
A defective viral genome strategy elicits broad protective immunity against respiratory viruses
Yinghong Xiao, Peter V. Lidsky, Yuta Shirogane, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6037-6051.e14
Open Access | Times Cited: 54
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner, et al.
JAMA (2022) Vol. 328, Iss. 15, pp. 1523-1523
Open Access | Times Cited: 30
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Katherine Ellingson, James Hollister, Cynthia Porter, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 599-604
Open Access | Times Cited: 13
The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data
Carmen-Daniela Chivu, Maria Crăciun, Daniela Piţigoi, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 182-182
Open Access | Times Cited: 4
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies
James Hollister, Alberto J. Caban‐Martinez, Katherine Ellingson, et al.
Environmental Research (2023) Vol. 239, pp. 117297-117297
Open Access | Times Cited: 9
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers
Karen Lutrick, Holly C. Groom, Ashley Fowlkes, et al.
Vaccine (2021) Vol. 40, Iss. 3, pp. 494-502
Open Access | Times Cited: 21
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 11, pp. 2461-2465
Open Access | Times Cited: 14
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Georgi K. Marinov, Младен Младенов, Antoni Rangachev, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274509-e0274509
Open Access | Times Cited: 13
Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona
Katherine Ellingson, Joe K. Gerald, Xiaoxiao Sun, et al.
JAMA Health Forum (2021) Vol. 2, Iss. 10, pp. e213318-e213318
Open Access | Times Cited: 15
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection
Harmony L. Tyner, Jefferey L. Burgess, Lauren Grant, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e827-e837
Open Access | Times Cited: 13
Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021
Allison L. Naleway, Lauren Grant, Alberto J. Caban‐Martinez, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 3, pp. 585-593
Open Access | Times Cited: 9
High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study
Klaus Hirschbühl, Tina Schaller, Bruno Märkl, et al.
Modern Pathology (2022) Vol. 35, Iss. 8, pp. 1013-1021
Open Access | Times Cited: 9
Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years — PROTECT Cohort, Four States, July 2021–May 2022
Karen Lutrick, Ashley Fowlkes, Patrick Rivers, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 35, pp. 1109-1114
Open Access | Times Cited: 9
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study
Elizabeth B. White, Lauren Grant, Josephine Mak, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 1
Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study
Joy Burns, Patrick Rivers, Lindsay LeClair, et al.
JMIR Research Protocols (2022) Vol. 11, Iss. 7, pp. e37929-e37929
Open Access | Times Cited: 7
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses
Meghan K. Herring, James K. Romine, Meredith G. Wesley, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 10, pp. 1822-1831
Closed Access | Times Cited: 6
COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021
Alberto J. Caban‐Martinez, Manjusha Gaglani, Lauren E.W. Olsho, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222640-e2222640
Open Access | Times Cited: 5
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Georgi K. Marinov, Младен Младенов, Antoni Rangachev, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza
Zhu Nan Li, Feng Liu, Stacie Jefferson, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_2, pp. S271-S284
Open Access | Times Cited: 4
Hybrid Immunity and Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study
James K. Romine, Huashi Li, Melissa M. Coughlin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 96-107
Closed Access
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort
Cynthia Porter, Zoë L. Lyski, Jennifer L. Uhrlaub, et al.
Diseases (2024) Vol. 12, Iss. 8, pp. 171-171
Open Access
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study
Patrick Rivers, Cynthia Porter, Lindsay LeClair, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1512-1520
Open Access
Page 1 - Next Page

Scroll to top